Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT088 subcutaneous versus intramuscular hepatitis B immunoglobulin for perinatal prophylaxis in infants of HBsAg-positive mothers
2006-000110-21Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Jul 2006
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Fovepta in hepatitis B (HBV) (2 arms), sponsored by Biotest AG. Primary endpoint: Efficacy response rate. Started Jul 2006; status: completed.
02
Drugs
Fovepta
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2006-000110-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000110-21.